Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Quinoxaline-6-carboxaldehyde → 6-(2,6-Dimethoxyphenyl)-1-(quinoxalin-6-ylmethyl)piperidin-2-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Quinoxaline-6-carboxaldehyde | HCID 763958 | — |
| 반응물 | Methyl 5-amino-5-(2,6-dimethoxyphenyl)pentanoate | HCID 69082713 | — |
| 생성물 | 6-(2,6-Dimethoxyphenyl)-1-(quinoxalin-6-ylmethyl)piperidin-2-one | HCID 69083291 | — |
반응 단계
Prepared according to the described general procedure 1 (GP1) by reaction of methyl 5-amino-5-(2,6-dimethoxyphenyl)pentanoate with commercially available quinoxaline-6-carbaldehyde. Subsequent purification by preparative HPLC afforded the target compound. LC-MS (conditions A): tR=0.68 min.; [M+H]+: 378.17 g/mol.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09242970B2 |
| 출처 데이터셋 | uspto-grants-2016_01 |
| ORD ID | ord-473aa4eb336943609ea42eb15e4144c1 |
| 출처 메모 | uspto-grants-2016_01 |